• 1. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 2. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 3. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 4. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 5. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazanaphthalenes Quinazolines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazanaphthalenes Benzodiazines Quinazolines

7-Bromoquinazoline-2,4-diamine (CAS No. 137553-43-6): A Comprehensive Overview

7-Bromoquinazoline-2,4-diamine (CAS No. 137553-43-6) is a heterocyclic compound that has garnered significant attention in the fields of organic chemistry, pharmacology, and materials science. This compound belongs to the quinazoline family, which is a class of nitrogen-containing aromatic heterocycles. The presence of a bromine atom at the 7-position and amino groups at the 2 and 4 positions imparts unique chemical properties, making it a versatile molecule for various applications.

The synthesis of 7-Bromoquinazoline-2,4-diamine involves a series of well-established organic reactions. Typically, the starting material is a substituted aniline derivative, which undergoes condensation with an aldehyde or ketone in the presence of an acid catalyst to form the quinazoline skeleton. The introduction of the bromine atom at the 7-position is achieved through electrophilic aromatic substitution or other halogenation techniques. The resulting compound is then purified using chromatographic methods to ensure high purity levels.

Recent studies have highlighted the potential of 7-Bromoquinazoline-2,4-diamine in drug discovery and development. Due to its structural similarity to certain bioactive compounds, this molecule has been investigated for its anti-cancer properties. Research indicates that 7-Bromoquinazoline-2,4-diamine can inhibit key enzymes involved in cell proliferation and apoptosis, making it a promising candidate for targeted therapies.

In addition to its pharmacological applications, 7-Bromoquinazoline-2,4-diamine has also been explored in materials science. Its aromatic structure and functional groups make it suitable for use in organic electronics and optoelectronic devices. For instance, derivatives of this compound have been studied as candidates for organic light-emitting diodes (OLEDs) due to their ability to emit light under electrical stimulation.

The toxicity profile of 7-Bromoquinazoline-2,4-diamine has been evaluated in preclinical studies. Results suggest that while the compound exhibits potent biological activity, it also demonstrates moderate cytotoxicity against non-cancerous cells. This highlights the need for further research to optimize its selectivity and reduce potential side effects.

From a synthetic chemistry perspective, 7-Bromoquinazoline-2,4-diamine serves as a valuable building block for constructing more complex molecules. Its reactivity under various reaction conditions allows chemists to explore novel pathways for synthesizing bioactive compounds with enhanced properties.

In conclusion, 7-Bromoquinazoline-2,4-diamine (CAS No. 137553-43-6) is a multifaceted compound with applications spanning drug discovery, materials science, and synthetic chemistry. As research continues to uncover its potential uses and optimize its properties, this molecule is poised to play an increasingly important role in advancing scientific and technological frontiers.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)